Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

not_yet_recruiting133%
terminated133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

NCT06282614
not_yet_recruitingnot_applicable

The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)

NCT06585579
unknownnot_applicable

Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.

NCT04664985

Clinical Trials (3)

Showing 3 of 3 trials
NCT06282614Not Applicable

Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

Terminated
NCT06585579Not Applicable

The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)

Not Yet Recruiting
NCT04664985Not Applicable

Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3